This case report describes the use of low-dose naltrexone (LDN) in a patient with systemic sclerosis experiencing severe pruritus unresponsive to conventional treatments. Administration of LDN at 4.5 mg nightly resulted in significant improvement in pruritus intensity and sleep quality within two weeks, with sustained benefits over several months. The
